Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why Pradaxa is not a bad drug

John Mandrola, MD
Meds
May 23, 2012
Share
Tweet
Share

It’s crazy out there in blood thinner land.

The novel blood thinning drug for patients with atrial fibrillation, dabigatran (Pradaxa) cannot get a break.

It’s all over the TV: Pradaxa = Bad drug.

Look at this image:

On the prestigious heart news site, theheart.org, an insignificant 113-patient study presented as a poster at a small symposium — by a researcher with ties to anti-coagulation clinics — gets attention because a few patients on dabigatran developed well-known complications. Though the author makes important points, namely, that blood-thinners should be used cautiously and patients should be well-informed about the risks and benefits, the study added nothing to what is already known about dabigatran.

Gosh. I can’t believe I feel a twinge of empathy for a Big Pharma company.

Here’s a news flash.

Dabigatran and rivaroxaban are blood thinners. They lower the risk of stroke, but increase the risk of bleeding. It’s the same for warfarin. When these two agents were compared to warfarin in huge randomized controlled clinical trials, they both looked favorable.

For my entire career, I have heard the downsides of warfarin. Now, we have two drugs that prevent more strokes than warfarin, don’t require blood checks, have no dietary interactions, minimal drug-drug interactions and are not used to poison rats. Do they worsen bleeding when one falls? Yes. So does warfarin.

Folks, of course it is better to not have a disease that increases the risk of stroke. That’s what I have been saying since I started this blog. Prevention is better. Go to bed on time, exercise every day that you eat, eat less, drink fewer irritants, don’t sweat getting a B+ and smile at your neighbor. I know; these are hard therapies with which to adhere.

But blood thinners are not bad medicines. They are medicines. They have risks and they have benefits. And the alternative: a patient can have the disease and its inherent risks.

John Mandrola is a cardiologist who blogs at Dr John M.

Submit a guest post and be heard on social media’s leading physician voice.

Prev

A good doctor should rarely be surprised by test results

May 23, 2012 Kevin 5
…
Next

Patients are our best teachers

May 23, 2012 Kevin 1
…

Tagged as: Medications

Post navigation

< Previous Post
A good doctor should rarely be surprised by test results
Next Post >
Patients are our best teachers

ADVERTISEMENT

More by John Mandrola, MD

  • What we can learn about weight loss from Al Sharpton

    John Mandrola, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Don’t be foolish enough to think you control outcomes

    John Mandrola, MD
  • a desk with keyboard and ipad with the kevinmd logo

    The problem with Obamacare is that it doesn’t do enough

    John Mandrola, MD

More in Meds

  • Are you neurodivergent or just bored?

    Martha Rosenberg
  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • Most Popular

  • Past Week

    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • Why physicians must lead the vetting of medical AI [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why health care needs empathy, not just algorithms

      Muhammad Abdullah Khan | Conditions
    • Physician legal rights: What to do when agents knock

      Muhamad Aly Rifai, MD | Physician
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
  • Recent Posts

    • Physician legal rights: What to do when agents knock

      Muhamad Aly Rifai, MD | Physician
    • How to succeed in your medical training

      Jessica Favreau, MD | Education
    • Why medical malpractice data is hidden

      Howard Smith, MD | Physician
    • A financial vision to define your retirement [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI in medical imaging: When algorithms block the view

      Gerald Kuo | Tech
    • The danger of dismantling DEI in medicine

      Jacquelyne Gaddy, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 17 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • Why physicians must lead the vetting of medical AI [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why health care needs empathy, not just algorithms

      Muhammad Abdullah Khan | Conditions
    • Physician legal rights: What to do when agents knock

      Muhamad Aly Rifai, MD | Physician
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
  • Recent Posts

    • Physician legal rights: What to do when agents knock

      Muhamad Aly Rifai, MD | Physician
    • How to succeed in your medical training

      Jessica Favreau, MD | Education
    • Why medical malpractice data is hidden

      Howard Smith, MD | Physician
    • A financial vision to define your retirement [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI in medical imaging: When algorithms block the view

      Gerald Kuo | Tech
    • The danger of dismantling DEI in medicine

      Jacquelyne Gaddy, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Why Pradaxa is not a bad drug
17 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...